Skip to main content

Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research.


AUTHORS

Penson DF , Lin DW , Karsh L , Quinn DI , Shevrin DH , Shore N , Symanowski JT , Brown B , Forer D , Wong EK , Flanders SC , . Future oncology (London, England). 2016 8 16; ().
  • NIHMSID: 101256629

ABSTRACT

This study seeks to improve the understanding of treatment patterns and associated health-related quality of life (HRQoL), clinical outcomes and healthcare utilization in US patients with castration-resistant prostate cancer (CRPC).


This study seeks to improve the understanding of treatment patterns and associated health-related quality of life (HRQoL), clinical outcomes and healthcare utilization in US patients with castration-resistant prostate cancer (CRPC).


Tags: